AI
| Followers | 843 |
| Posts | 122802 |
| Boards Moderated | 10 |
| Alias Born | 09/05/2002 |
Thursday, May 02, 2013 6:16:17 PM
Interim-data table from GILD’s phase-2 LONESTAR study:
Ledipasvir is GS-5885 (an NS5A inhibitor).
Ledipasvir is GS-5885 (an NS5A inhibitor).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
